Beta Bionics, Inc.
BBNX
$10.20
$0.303.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.59% | 25.64% | -45.94% | -16.64% | -130.19% |
| Total Depreciation and Amortization | 63.41% | 76.75% | 11.06% | 13.37% | 7.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.64% | -15.12% | 269.33% | -4.96% | 214.71% |
| Change in Net Operating Assets | -26.92% | 53.48% | 118.59% | 44.19% | -32.60% |
| Cash from Operations | -19.31% | 39.58% | 9.20% | -11.09% | -64.48% |
| Capital Expenditure | -313.51% | -239.22% | 33.26% | -250.89% | 17.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 112.99% | 108.80% | -37.26% | 108.88% | -2,334.86% |
| Cash from Investing | 112.19% | 102.22% | -37.76% | 87.06% | -2,443.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.70% | 2,689.47% | 5,667.39% | 250.00% | 3,518,550.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.70% | -98.14% | 325.60% | 139.25% | 3,518,550.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.40% | -153.35% | -23.42% | 18.41% | 367.51% |